Target intelligence / Profile preview

Immunoglobulin lambda variable 5-39 (IGLV5-39)

Target
IGLV5-39
Molecular classification
Immunoglobulin variable region, Immunoglobulin light chain (lambda family), Other (as it is neither an enzyme, transporter, GPCR, etc.)
01

Overview

Immunoglobulin lambda variable 5-39 is one of the gene segments encoding the variable domain of the lambda light chain in antibodies. These genes undergo somatic recombination in B lymphocytes to generate the immense diversity of antibodies required for specific antigen recognition. The variable domain, together with a heavy chain variable domain, forms the antigen-binding site of the antibody. Aberrant clonal expansion of B cells expressing particular immunoglobulin variable genes can be associated with malignancy or autoimmune disease. Immunoglobulin lambda variable genes are markers of B cell clonality and are important in adaptive immunity, but are not direct targets for small-molecule drugs or biologics unless engineered as part of bespoke therapeutic antibodies.

Other names
IGLV5-39Immunoglobulin lambda variable region 5-39LV539_HUMAN
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Cancer (e.g., certain B-cell malignancies with monoclonal immunoglobulin rearrangements)Autoimmune and inflammatory diseases (through aberrant or clonal antibody production)Other (biomarkers for lymphoproliferative disorders)
04

Safety considerations

Monoclonal gammopathies (risk when variable regions clonally expand, leading to diseases like multiple myeloma)Potential off-target immune effects if engineered as part of therapeutic antibodies
05

Biomarkers

Clonal rearrangements of immunoglobulin lambda variable genes (including IGLV5-39) are used as biomarkers in diagnosing and monitoring B-cell malignancies (e.g., multiple myeloma, lymphoma)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 5-39 (IGLV5-39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 5-39 (IGLV5-39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call